Obesity drug sails through trials
Orexigen Therapeutics reports that its obesity drug Contrave has sailed through two late-stage trials and surpassed US Food and Drug Administration effectiveness requirements.
A combo pill of two addiction drugs can help people lose weight, say US researchers.